bioAffinity Technologies Inc

General ticker "BIAF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $13.3M

bioAffinity Technologies Inc does not follow the US Stock Market performance with the rate: -18.9%.

Estimated limits based on current volatility of 10.2%: low 0.93$, high 1.14$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.03$, 2.39$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.07$, 2.45$]

Similar symbols

Short-term BIAF quotes

Long-term BIAF plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $2.53MM
Operating Expenses $2.21MM $4.02MM $10.51MM
Operating Income $-2.21MM $-4.01MM $-7.97MM
Non-Operating Income $-4.12MM $-4.14MM $0.06MM
Interest Expense $1.00MM $2.53MM $0.04MM
R&D Expense $1.33MM $1.29MM $1.72MM
Income(Loss) $-6.32MM $-8.15MM $-7.92MM
Taxes $0.00MM $0.00MM $0.02MM
Profit(Loss) $-6.33MM $-8.15MM $-7.94MM
Stockholders Equity $-15.79MM $11.04MM $4.86MM
Inventory $0.07MM $0.01MM $0.02MM
Assets $1.45MM $12.18MM $8.22MM
Operating Cash Flow $-2.05MM $-4.07MM $-6.04MM
Capital expenditure $0.00MM $0.22MM $0.02MM
Investing Cash Flow $0.00MM $-0.22MM $-2.21MM
Financing Cash Flow $3.33MM $14.34MM $-0.34MM
Earnings Per Share* $-0.86 $-1.81 $-0.91

* EPS are Split Adjusted, recent splits may be reflected with a delay.